Some people infected with HIV are teeming with virus, but don’t get sick. Their resistive powers probably come from a mix of ...

The 5th HIV Research for Prevention Conference (HIVR4P 2024) held in Lima, Peru, marked a significant milestone in the global ...

HIV Research for Prevention Conference ANALYSIS | SETHI NCUBE | The 5th HIV Research for Prevention Conference (HIVR4P 2024) ...

Finding out you have HIV can be scary and intimidating news, but so much has changed that now people can lead long and ...

From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

HIV, stands for the human immunodeficiency virus, it attacks the cells in your immune system making it hard for your body to ...

Sweden has reached the UNAIDS and WHO targets for the HIV epidemic, according to a study in Eurosurveillance by researchers ...

Gilead Sciences, the maker of a twice-a-year anti-HIV injection, has approached South Africa’s medicine regulator to discuss ...

Code Pharma, a pioneering pharmaceutical company headquartered in the Netherlands, is set to present groundbreaking findings from its clinical trials on GAMMORA, a drug aimed at treating HIV, at two ...

Natal, alarming gaps between scientific advancements and community behaviour persist. This article explores the critical need ...

The second of two pivotal studies of a six-monthly HIV prevention injection containing the antiretroviral drug lenacapavir ...